Harsh P. Patel

Harsh P. Patel

Auto-generated profile, based on publicly available information

Harsh P. Patel

Southern Illinois University School of Medicine, UNITED STATES

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in The American Journal of Cardiology
Verified
Journal Article
Closed access
SAShilpkumar Arora
Shilpkumar Arora
RJRahul Jaswaney
Rahul Jaswaney
CJChinmay T. Jani
Chinmay T. Jani
ZZZachary Zuzek
Zachary Zuzek
STSamarthkumar Thakkar
Samarthkumar Thakkar
ADAbhishek Deshmukh
Abhishek Deshmukh

29 May 2023 in Postgraduate Medicine
Verified
Journal Article
Closed access
STSahith Reddy Thotamgari
Sahith Reddy Thotamgari
ASAakash R. Sheth
Aakash R. Sheth
HPHarsh P. Patel
Harsh P. Patel
HSHarigopal Sandhyavenu
Harigopal Sandhyavenu
BPBhavin Patel
Bhavin Patel
PDPaari Dominic
Paari Dominic
BackgroundAtrial fibrillation (AF) is the most common arrhythmia in patients with cancer, especially breast, gastrointestinal, respiratory, urinary tract, and hematological malignancies. Catheter ablation (CA) is a well-established, safe treatment option in healthy patients; however, literature regarding safety of CA for AF in patients with cancer is limited and confined to single centers.ObjectiveWe aimed to assess the outcomes and peri-procedural safety of CA for AF in patients with certain types of cancer.MethodsThe NIS database was queried between 2016 and 2019 to identify primary hospitalizations with AF and CA. Hospitalizations with secondary diagnosis of atrial flutter and other arrhythmias were excluded. Propensity score matching was used to balance the covariates between cancer and non-cancer groups. Logistic regression was used to analyze the association.ResultsDuring this period, 47,765 CA procedures were identified, out of which 750 (1.6%) hospitalizations had a diagnosis of cancer. After propensity matching, hospitalizations with cancer diagnosis had higher in-hospital mortality (OR 3.0, 95% CI 1.5-6.2, p = 0.001), lower home discharge rates (OR 0.7, 95% CI 0.6-0.9, p < 0.001) as well as other complications such as major bleeding (OR 1.8, 95% CI 1.3-2.7, p = 0.001) and pulmonary embolism (OR 6.1, 95% CI 2.1-17.8, p < 0.001) but not associated with any major cardiac complications (OR 1.2, 95% CI 0.7-1.8, p = 0.53).ConclusionPatients with cancer who underwent CA for AF had significantly higher odds of in-hospital mortality, major bleeding, and pulmonary embolism. Further larger prospective observational studies are needed to validate these findings.

11 October 2021 in Heart Rhythm O2
Verified
Journal Article
Open access
STSamarthkumar Thakkar
Samarthkumar Thakkar
HPHarsh P. Patel
Harsh P. Patel
LBLeela Krishna Teja Boppana
Leela Krishna Teja Boppana
MFMohammad Faisaluddin
Mohammad Faisaluddin
DRDevesh Rai
Devesh Rai
ADAbhishek Deshmukh
Abhishek Deshmukh
Atrial arrhythmias are commonly noted in patients with alcohol withdrawal syndrome (AWS), requiring inpatient admission. The burden of arrhythmias and the association with in-hospital outcomes are incompletely defined in patients hospitalized with AWS. The nationwide inpatient sample database was accessed from September 2015 to December 2018 to identify hospitalizations for AWS. We studied a cohort of patients with arrhythmias noted during hospitalization using the appropriate International Classification of Diseases, Tenth Revision billing codes. We compared patient characteristics, outcomes, and hospitalization costs between alcohol withdrawal hospitalizations with and without documented arrhythmias. Propensity score matching (PSM) and multivariate regression were performed to control confounders and develop odds ratios (OR), respectively. Among 1,511,155 hospitalization with AWS, 146,825 (9.72%) had concurrent arrhythmias. After PSM, we identified 135,540 cases in each group. Hospitalizations with AWS and concurrent arrhythmias had higher in-hospital mortality (4.19% vs 1.95%, OR 1.76, confidence interval [CI] 1.67–1.85, P < .0001). The most common arrhythmia was atrial fibrillation (66.7%). Arrhythmias in AWS were also associated with poorer in-hospital outcomes, including a higher risk of acute heart failure (8.40% vs 4.58%, OR 1.97, CI 1.90–2.05, P < .0001), acute kidney injury (21.32% vs 15.27%, OR 1.39, CI 1.36–1.43, P < .0001), and acute respiratory failure (9.19% vs 5.49%, OR 1.70, CI 1.64–1.76, P < .0001) requiring intubation. The length of hospital stay (6 days vs 4 days P < .0001) and cost of hospital care ($12,615 [$6683–$27,330] vs $7860 [$4482–$15,868], P < .0001) were higher in AWS with arrhythmias. Arrhythmia in AWS is associated with higher in-hospital mortality and poorer in-hospital outcomes.

14 September 2023 in Methodist DeBakey Cardiovascular Journal
Verified
Journal Article
Open access
PDF file
HBHemanth K. Boppana
Hemanth K. Boppana
STSamarthkumar Thakkar
Samarthkumar Thakkar
HPHarsh P. Patel
Harsh P. Patel
RCRody G. Bou Chaaya
Rody G. Bou Chaaya
SFScott Feitell
Scott Feitell
McLeod’s syndrome (MLS) is an X-linked disorder caused by mutations in the XK gene with neurological manifestations as well as cardiomyopathy. This is a case of acute exacerbation of heart failure in a 44-year-old White male with a confirmed diagnosis of MLS, which was managed with guideline-directed medical therapy and placement of an implantable cardioverter defibrillator with recovery in ejection fraction.

11 August 2020 in medRxiv
Verified
Preprint
Open access
PDF file
STSamarthkumar Thakkar
Samarthkumar Thakkar
SAShilpkumar Arora
Shilpkumar Arora
AKAshish Kumar
Ashish Kumar
RJRahul Jaswaney
Rahul Jaswaney
MFMohammed Faisaluddin
Mohammed Faisaluddin
ADAbhishek Deshmukh
Abhishek Deshmukh
The impact of coronavirus disease, 2019 (COVID-19), has been profound. Though COVID-19 primarily affects the respiratory system, it has also been associated with a wide range of cardiovascular (CV) manifestations portending extremely poor prognosis. The principal hypothesis for CV involvement is through direct myocardial infection and systemic inflammation. We conducted a systematic review of the current literature to provide a foundation for understanding the CV manifestations and outcomes of COVID-19. PubMed and EMBASE databases were electronically searched from the inception of the databases through April 27th, 2020. A second literature review was conducted to include major trials and guidelines that were published after the initial search but before submission. The inclusion criteria for studies to be eligible were case reports, case series, and observation studies reporting CV outcomes among patients with COVID-19 infection. This review of the current COVID-19 disease and CV outcomes literature revealed a myriad of CV manifestations with potential avenues for treatment and prevention. Future studies are required to understand on a more mechanistic level the effect of COVID-19 on the myocardium and thus provide avenues to improve mortality and morbidity.

18 May 2023 in Journal of the Society for Cardiovascular Angiography & Interventions
Verified
Journal Article
Open access
MFMohammed Faisaluddin
Mohammed Faisaluddin
AAAsmaa Ahmed
Asmaa Ahmed
HPHarsh P. Patel
Harsh P. Patel
STSamarthkuamr Thakkar
Samarthkuamr Thakkar
YSyasar sattar
yasar sattar
MAMahboob Alam
Mahboob Alam